Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Evolve Biologics

Clinical trials sponsored by Evolve Biologics, explained in plain language.

New antibody replacement therapy aims to shield vulnerable patients from serious infections

Disease control Completed

This study tests a new intravenous immunoglobulin (IGIV) called PlasmaCap IG in adults and children aged 2 to 70 with primary immune deficiency diseases (PIDD). Participants receive regular infusions of the therapy for 12 months. The goal is to see if it prevents serious bacteria…

Phase 3 • Sponsor: Evolve Biologics • Aim: Disease control

Last updated Jul 02, 2026 00:00 UTC